GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Lifted by Seven Grand Managers LLC

Seven Grand Managers LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 150.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 250,000 shares of the company’s stock after buying an additional 150,000 shares during the period. GE HealthCare Technologies makes up approximately 5.3% of Seven Grand Managers LLC’s investment portfolio, making the stock its 4th largest position. Seven Grand Managers LLC’s holdings in GE HealthCare Technologies were worth $23,462,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Pathway Financial Advisers LLC acquired a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $25,000. Fred Alger Management LLC purchased a new stake in shares of GE HealthCare Technologies during the second quarter worth $26,000. BNP Paribas acquired a new stake in GE HealthCare Technologies during the first quarter valued at $30,000. Rise Advisors LLC grew its stake in GE HealthCare Technologies by 241.4% in the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares in the last quarter. Finally, Riverview Trust Co acquired a new position in GE HealthCare Technologies in the 1st quarter worth about $31,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on GEHC. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research report on Wednesday, September 18th. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target on the stock. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, Evercore ISI raised their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.23.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $90.22 on Thursday. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55. The company has a market cap of $41.18 billion, a P/E ratio of 26.38, a P/E/G ratio of 3.39 and a beta of 1.18. The business’s 50 day moving average is $87.58 and its two-hundred day moving average is $83.36. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the previous year, the firm posted $0.92 earnings per share. GE HealthCare Technologies’s revenue was up .5% compared to the same quarter last year. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.